| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,654 |
7,652 |
$772K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,467 |
2,375 |
$264K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,015 |
1,951 |
$217K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,382 |
1,277 |
$167K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,551 |
1,461 |
$153K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,167 |
1,142 |
$139K |
| D1206 |
Topical application of fluoride varnish |
2,812 |
2,773 |
$69K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
7,980 |
7,688 |
$68K |
| 90686 |
|
2,884 |
2,744 |
$64K |
| 92579 |
|
1,528 |
1,457 |
$53K |
| 92552 |
|
1,607 |
1,552 |
$40K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
659 |
613 |
$36K |
| 90698 |
|
1,472 |
1,401 |
$33K |
| 90677 |
|
319 |
302 |
$27K |
| 90670 |
|
1,174 |
1,115 |
$26K |
| 96127 |
|
5,265 |
5,069 |
$24K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
209 |
202 |
$24K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
483 |
451 |
$21K |
| 90633 |
|
770 |
725 |
$17K |
| 82465 |
|
3,666 |
3,541 |
$15K |
| 96160 |
|
5,057 |
4,898 |
$14K |
| 82947 |
|
3,648 |
3,527 |
$12K |
| 90651 |
|
509 |
496 |
$12K |
| 90744 |
|
537 |
498 |
$12K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
781 |
573 |
$9K |
| 83655 |
|
763 |
714 |
$8K |
| 85014 |
|
3,528 |
3,407 |
$8K |
| 85018 |
|
3,525 |
3,404 |
$8K |
| 90656 |
|
347 |
331 |
$8K |
| 99383 |
|
60 |
60 |
$7K |
| 90681 |
|
330 |
313 |
$7K |
| 99173 |
|
2,758 |
2,669 |
$7K |
| 90619 |
|
206 |
201 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
454 |
430 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
35 |
28 |
$5K |
| 90710 |
|
185 |
181 |
$4K |
| 99384 |
|
25 |
25 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
164 |
161 |
$4K |
| 0071A |
|
89 |
82 |
$3K |
| 96161 |
|
1,155 |
1,082 |
$3K |
| 0072A |
|
75 |
69 |
$3K |
| 90696 |
|
107 |
107 |
$2K |
| 90715 |
|
106 |
105 |
$2K |
| 90734 |
|
108 |
105 |
$2K |
| 99215 |
Prolong outpt/office vis |
16 |
14 |
$2K |
| 87428 |
|
60 |
58 |
$2K |
| 90716 |
|
80 |
67 |
$2K |
| 96112 |
|
14 |
13 |
$2K |
| 99382 |
|
13 |
13 |
$1K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$1K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
184 |
182 |
$1K |
| 90707 |
|
41 |
39 |
$931.20 |
| 81003 |
|
410 |
399 |
$849.84 |
| 87807 |
|
32 |
31 |
$330.79 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
13 |
13 |
$260.41 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
15 |
$247.19 |
| 36416 |
|
2,091 |
1,279 |
$246.50 |
| 81000 |
|
99 |
82 |
$227.92 |
| 87420 |
|
17 |
14 |
$153.01 |
| 36415 |
Collection of venous blood by venipuncture |
81 |
81 |
$121.50 |